Table 4 Adverse events after non-cardiac surgeries associated with components of CHA2DS2-VASc score
Components of CHA2DS2-VASc score | N | Postoperative adverse events* | ||
|---|---|---|---|---|
Events | Rate, % | OR (95% CI)†| ||
Control group (0 score) | 1763 | 160 | 9.1 | 1.00 (reference) |
Patient with | ||||
 Age ≥ 75 years (≥ 2 scores) | 24,919 | 6394 | 25.7 | 3.53 (2.98–4.18) |
 Stroke (≥ 2 scores) | 6865 | 1949 | 28.4 | 2.14 (1.78–2.58) |
 Age 65–74 years (≥ 1 score) | 12,622 | 2215 | 17.6 | 2.13 (1.79–2.52) |
 Congestive heart failure (≥ 1 score) | 11,232 | 2934 | 26.1 | 1.93 (1.60–2.31) |
 Vascular disease (≥ 1 score) | 13,488 | 2871 | 21.3 | 1.51 (1.26–1.81) |
 Diabetes (≥ 1 score) | 12,491 | 2930 | 23.5 | 1.82 (1.51–2.18) |
 Female (≥ 1 score) | 19,644 | 3979 | 20.3 | 1.62 (1.35–1.94) |
 Hypertension (≥ 1 score) | 27,894 | 5972 | 21.4 | 1.53 (1.28–1.84) |
CHA2DS2-VASc score | ||||
 0 | 1763 | 160 | 9.1 | 1.00 (reference) |
 1 | 7214 | 1205 | 16.7 | 1.47 (1.22–1.76) |
 2 | 12,419 | 2458 | 19.8 | 1.55 (1.29–1.87) |
 3 | 12,894 | 2750 | 21.3 | 1.61 (1.33–1.95) |
 4 | 8314 | 1994 | 24.0 | 1.74 (1.44–2.12) |
 ≥ 5 | 4798 | 1310 | 27.3 | 1.96 (1.60–2.41) |